Global Vacuum-assisted Breast Biopsy(VAB)System Market Strategic Research Report

Scope of the Report

The global Vacuum-assisted Breast Biopsy(VAB)System market size is predicted to grow from US$ 1,564 million in 2025 to US$ 3,080 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Vacuum-assisted breast biopsy (VAB) systems are minimally invasive, image-guided medical devices used to obtain multiple tissue samples from suspicious breast lesions through a single needle insertion by applying controlled vacuum suction. These systems are commonly integrated with ultrasound, stereotactic mammography, or MRI guidance and are widely used in hospitals, diagnostic imaging centers, and breast care clinics as alternatives to open surgical biopsy. From a value chain perspective, upstream activities include precision mechanical components, vacuum modules, imaging interfaces, disposable biopsy needles, and sterile packaging materials, midstream processes focus on system assembly, software integration, calibration, sterilization validation, and regulatory compliance, while downstream demand is driven by hospitals, diagnostic imaging centers, and specialized breast clinics. In 2025, the average selling price of VAB systems is approximately US$19,500 per system, with global sales volume reaching around 82 thousand systems. The industry maintains a gross margin of 45%–65%, supported by proprietary device platforms, recurring disposable needle sales, clinical switching costs, and reimbursement-driven adoption of minimally invasive diagnostics.

The VAB market is expanding rapidly as minimally invasive breast diagnostics become standard practice. Rising breast cancer screening rates, improved imaging compatibility, and strong recurring revenue from disposable needles drive long-term growth. MRI-guided VAB and automated vacuum systems are expected to capture increasing market share through 2031.Industry analysis indicates that VAB systems are increasingly positioned as standard diagnostic tools in breast lesion assessment rather than niche biopsy options. Growth is driven by early cancer screening programs, preference for minimally invasive procedures, and bundled device-plus-consumables business models, shifting competition toward procedural efficiency, imaging compatibility, and needle portfolio breadth.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vacuum-assisted Breast Biopsy(VAB)System market?

What factors are driving Vacuum-assisted Breast Biopsy(VAB)System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vacuum-assisted Breast Biopsy(VAB)System market opportunities vary by end market size?

How does Vacuum-assisted Breast Biopsy(VAB)System break out by Type, by Application?

This report presents a comprehensive overview of the global Vacuum-assisted Breast Biopsy(VAB)System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Single Vacuum Type
• Double Vacuum Type

Segment by Needle Type

• 7G VAB Needle
• 9G Needle
• 10G / 11G Needle

Segment by Targeting Method

• Manual Targeting
• Semi-automatic Targeting
• Integrated Navigation System

Segment by Application

• Hospitals
• Diagnostic Imaging Centers
• Breast Specialty Clinics

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vacuum-assisted Breast Biopsy(VAB)System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Diagnostic Imaging Centers, Breast Specialty Clinics evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact